Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Eichhorst, B., Robak, T., Montserrat, E., Ghia, P., Niemann, C.U., Kater, A.P., Gregor, M., Cymbalista, F., Buske, C., Hillmen, P., Hallek, M., Mey, U.

Volltext

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation von Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.

Volltext

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia von Pospisilova, S, Gonzalez, D, Malcikova, J, Trbusek, M, Rossi, D, Kater, A P, Cymbalista, F, Eichhorst, B, Hallek, M, Döhner, H, Hillmen, P, van Oers, M, Gribben, J, Ghia, P, Montserrat, E, Stilgenbauer, S, Zenz, T

Volltext

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research In... von Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P

Volltext

ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia von Eichhorst, B., Ghia, P., Niemann, C.U., Kater, A.P., Gregor, M., Hallek, M., Jerkeman, M., Buske, C.

Volltext

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia von Blume, C J, Hotz-Wagenblatt, A, Hüllein, J, Sellner, L, Jethwa, A, Stolz, T, Slabicki, M, Lee, K, Sharathchandra, A, Benner, A, Dietrich, S, Oakes, C C, Dreger, P, te Raa, D, Kater, A P, Jauch, A, Merkel, O, Oren, M, Hielscher, T, Zenz, T

Volltext

Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition von Slinger, E, Thijssen, R, Kater, A P, Eldering, E

Volltext

The impact of SF3B1 mutations in CLL on the DNA-damage response von te Raa, G D, Derks, I A M, Navrkalova, V, Skowronska, A, Moerland, P D, van Laar, J, Oldreive, C, Monsuur, H, Trbusek, M, Malcikova, J, Lodén, M, Geisler, C H, Hüllein, J, Jethwa, A, Zenz, T, Pospisilova, S, Stankovic, T, van Oers, M H J, Kater, A P, Eldering, E

Volltext

ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia von Tonino, S H, van Laar, J, van Oers, M H, Wang, J Y, Eldering, E, Kater, A P

Volltext

Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professiona... von Kater-Kuipers, A, Bunnik, E M, de Beaufort, I D, Galjaard, R J H

Volltext

Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia von Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W., Levin, M-D.

Volltext

BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future von Spaargaren, M, de Rooij, M F M, Kater, A P, Eldering, E

Volltext

Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989–2008 von van den Broek, E.C, Kater, A.P, van de Schans, S.A.M, Karim-Kos, H.E, Janssen-Heijnen, M.L.G, Peters, W.G, Nooijen, P.T.G.A, Coebergh, J.W.W, Posthuma, E.F.M

Volltext

P607: A NOVEL LYMPH NODE‐MIMICKING 3D CULTURE SYSTEM DISPLAYS LONG‐TERM T CELL‐DEPENDENT CLL PROLIFERATION AND SURVIVAL von Haselager, M., Perelaer, E., Kater, A., Eldering, E.

Volltext

EPCORITAMAB MONOTHERAPY AND COMBINATIONS IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR RICHTER’S SYNDROME: NEW ESCALATION AND EXPANSION COHORTS IN EPCORE CLL‐1 von Eichhorst, B., Eradat, H., Niemann, C. U., Oki, T., Kuznetsova, A., Rios, M., Valentin, R., Kater, A. P.

Volltext

Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia von van Attekum, M H A, Terpstra, S, Slinger, E, von Lindern, M, Moerland, P D, Jongejan, A, Kater, A P, Eldering, E

Volltext

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing tr... von Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., Sant'Antonio, E., Colia, M., Combi, C., Levi, S., Kater, A. P., Hazenberg, M., Nijhof, I. S., Hofsink, Q., Demosthenous, C., Kotaskova, J., Zaleska, J., Vrbacky, F., Raya, A. Mora, Bisogno, D., Tripoli, I. E., Popov, V. M., Roman, V., Stavroyianni, N., Karypidou, M., Scarano, E., Locatelli, M., Frenquelli, M., Scarfò, L., Stamatopoulos, K., Ghia, P.

Volltext

Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40 TLR9 triggering von Tromp, J M, Tonino, S H, Elias, J A, Jaspers, A, Luijks, D M, Kater, A P, van Lier, R A W, van Oers, M H J, Eldering, E

Volltext

Dichotomy in NF-[kappa]B signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering von Tromp, J M, Tonino, S H, Elias, J A, Jaspers, A, Luijks, D M, Kater, A P, Van Lier, R A W, Van Oers, M H J, Eldering, E

Volltext

Characterization of Mechanisms of Resistance in Previously Treated Chronic Lymphocytic Leukemia (CLL) From a Head‐to‐Head Trial of Acalabrutinib Versus Ibrutinib von Woyach, J. A., Jones, D., Jurczak, W., Robak, T., Illés, A., Kater, A. P., Ghia, P., Byrd, J. C., Seymour, J. F., Long, S., Mohamed, N., Jesus, G., Lai, R., Bruin, G., Butturini, A., Rule, S., Munugalavadla, V.

Volltext